When was Epocal founded?

Epocal was founded in 2001 and raised its 1st funding round within a year of its incorporation.

Where is Epocal located?

Epocal is headquartered in Ottawa, Canada.

How many employees does Epocal have?

As of May 31, 2026, the latest employee count at Epocal is 51742.

Is Epocal a funded company?

Epocal is a funded company, having raised a total of $40.5M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2001.

When was the latest funding round of Epocal?

Epocal's latest funding was a $***** Series C round on Apr 11, 2007, with participation from 2 investors.

Where does Epocal rank among its competitors?

Epocal ranks 7th amongst 36 active competitors, of which 8 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Jana Care, which secured $1.39M in Mar, 2026.

Who are the top competitors of Epocal?

Epocal's top competitors include Jana Care, Daxor and Pathshodh Healthcare. Among them, Jana Care secured the most recent funding round in March, 2026.

Epocal - 2026 Company Profile, Team, Funding & Competitors

Company Details

Epocal researches and develops biochips and solid-state diagnostic devices. Epocal is implementing an entire blood diagnostic system in FlexCard technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing. The company's new enterprise point-of-care blood diagnostic system, the Epoc comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes.

Website: epocal.com
Email ID: *****@alere.com

Key Metrics

Founded Year

2001

Location

Ottawa, Canada

Stage

Acqui-Hired

Total Funding

$40.5M in 6 rounds

Latest Funding Round

Series C, Apr 11, 2007, $*****

Investors

Genesys Capital & 3 more

Ranked

7^th among 36 active competitors

Employee Count

51,742 as on May 31, 2026

Similar Companies

Jana Care & 41 more

View Epocal's full profile

Epocal has raised a total funding of $40.5M over 6 rounds. Its first funding round was on 2001. Its latest funding round was a Series C round on Apr 11, 2007 for $*****. 2 investors participated in its latest round. Epocal has 4 institutional investors.

Here is the list of recent funding rounds of Epocal:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 11, 2007	3378862	Series C	3500222	4832824	8875051	1173548
Jan 25, 2006	4711745	Venture Debt	8612400	1403189	3856058	MMV Financial
Apr 12, 2005	6990173	Series B	7596051	6409474	6974948	7030362

Access funding benchmarks and valuations. Sign up today!

View details of Epocal's funding rounds and investors

The founders of Epocal is Imant Lauks.

Here are the details of Epocal's key team members:

Imant Lauks: CEO & Founder of Epocal.

View details of Epocal's Founder profiles and Board Members

Epocal's employee count trend

Epocal has 51,742 employees as of May 26. Here is Epocal's employee count trend over the years:

Uncover Epocal's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Epocal include Jana Care, Daxor and Pathshodh Healthcare. Here is the list of Top 10 competitors of Epocal, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jana Care 2011, Newton (United States), Series C	Provider of mobile-based healthcare diagnostics for diabetes prevention	$35.7M	IAG Capital Partners, MK Energy & 16 others	63/100
2nd	Daxor 1970, New York City (United States), Public	Developer of blood volume analyzer	-	NIGMS, HHS	49/100
3rd	Pathshodh Healthcare 2015, Bengaluru (India), Seed	Developer of handheld medical diagnostic devices. This company develops and manufactures portable devices for measuring multiple biomarkers related to diabetes, kidney disease, anemia, malnutrition, and liver ailments. The devices provide rapid, point-of-care diagnostic testing, enabling healthcare professionals to obtain results quickly. The technology aims to improve healthcare access and affordability.	$406K	IKP Knowledge Park, Foundation for Science Innovation and Development ... & 9 others	46/100
4th	Neuranics Lab 2021, Delhi (India), Seed	Developer of blood diagnostic systems using microfluidic cartridges and imaging	$1.48M	iHub Anubhuti, Inflection Point Ventures ... & 31 others	42/100
5th	Promea Therapeutics 2017, Patancheruvu (India), Funding Raised	Manufacturer of life science products and diagnostics	-	C-CAMP, BIRAC	42/100
6th	Essenlix 2013, Monmouth Junction (United States), Series A	Provider of mobile health self test platform	$20M	J&M Partners, NPX Capital Private Equity & 3 others	38/100
7th	Epocal 2001, Ottawa (Canada), Acqui-Hired	Biochips and Solid state diagnostic devices	$40.5M	Genesys Capital, MMV Financial & 2 others	37/100
8th	Cellmic 2009, Los Angeles (United States), Acquired	Rapid test readers for chromatographic and fluorescent assays	$5M	UCLA, NIBIB & 2 others	37/100
9th	Adsys 2021, Jaipur (India), Seed	Provider of AI-based device for rapid blood diagnosis	$154K	Rainmatter, Social Alpha & 2 others	36/100
10th	Hemcheck 2010, Karlstad (Sweden), Public	Provider of a device to identify non-analyzed blood samples	$448K	Almi Invest, Alfvén & Didrikson & 2 others	36/100